Rapport Therapeutics Inc
NASDAQ:RAPP

Watchlist Manager
Rapport Therapeutics Inc Logo
Rapport Therapeutics Inc
NASDAQ:RAPP
Watchlist
Price: 29.64 USD 3.35%
Market Cap: 1.4B USD

Wall Street
Price Targets

RAPP Price Targets Summary
Rapport Therapeutics Inc

Wall Street analysts forecast RAPP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RAPP is 52.53 USD with a low forecast of 34.34 USD and a high forecast of 84 USD.

Lowest
Price Target
34.34 USD
16% Upside
Average
Price Target
52.53 USD
77% Upside
Highest
Price Target
84 USD
183% Upside
Rapport Therapeutics Inc Competitors:
Price Targets
ANIP
ANI Pharmaceuticals Inc
32% Upside
867
China Medical System Holdings Ltd
27% Upside
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
8% Upside
4540
Tsumura & Co
5% Upside
2005
SSY Group Ltd
36% Upside
4015
Jamjoom Pharmaceuticals Factory Company SJSC
14% Upside
SUPN
Supernus Pharmaceuticals Inc
21% Upside
HIKAL
Hikal Ltd
30% Upside

Revenue
Forecast

Revenue Estimate
Rapport Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Rapport Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Rapport Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RAPP's stock price target?
Price Target
52.53 USD

According to Wall Street analysts, the average 1-year price target for RAPP is 52.53 USD with a low forecast of 34.34 USD and a high forecast of 84 USD.

Back to Top